STAAR SURGICAL CO (STAA) › Cash & EquivalentsSTAAR SURGICAL CO (STAA) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $6.33M2010: $9.38M2011: $16.58M2012: $21.68M2014: $22.95M2015: $13.01M2016: $14.00M2017: $18.52M2018: $103.88M2020: $119.97M2021: $199.71M2022: $86.48M2023: $183.04M2024: $144.16M2026: $153.15M$153.15M2009Cash & Equivalents (USD)2026Fiscal YearCash & EquivalentsChange YoY2026$153.15M—2024$144.16M-21.2%2023$183.04M+111.7%2022$86.48M-56.7%2021$199.71M+66.5%2020$119.97M—2018$103.88M+460.9%2017$18.52M+32.3%2016$14.00M+7.6%2015$13.01M-43.3%2014$22.95M—2012$21.68M+30.7%2011$16.58M+76.9%2010$9.38M+48.1%2009$6.33M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share